Get new jobs by email

  • Director, CMC Project Leadership

    $162.68k - $244.02k

     ...trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. In addition, Fusion is pursuing combination programs between RCs and DNA... 
    Suggested
    Temporary work
    Work at office

    Fusion Pharmaceuticals

    Boston, MA
    25 days ago

  • Imaging Scientist, Theranostics

    $86.68k - $130.03k

     ...trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. Fusion has multiple other pipeline programs that will soon be entering into... 
    Suggested
    Temporary work
    Work at office

    Fusion Pharmaceuticals LLC

    Chelsea, MA
    2 hours agonew

  • Associate Director, Clinical Supply Chain

    $115.75k - $173.62k

     ...trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. In addition, Fusion is pursuing combination programs between RCs and DNA... 
    Suggested
    Temporary work
    Work at office
    Flexible hours

    Fusion Pharmaceuticals LLC

    Providence, RI
    2 hours agonew